Is temsirolimus more safe and effective than interferon alpha for the treatment of advanced renal cell carcinoma?

Affiliations

¹ Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Center, The Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH 44195, USA.

Comment

Ali-Reza Golshayan et al. Nat Clin Pract Urol. 2007 Nov.

. 2007 Nov;4(11):586-7.

doi: 10.1038/ncpuro0915. Epub 2007 Sep 4.

¹ Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Center, The Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH 44195, USA.

No abstract available

Comment on

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.
Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ; Global ARCC Trial. Hudes G, et al. N Engl J Med. 2007 May 31;356(22):2271-81. doi: 10.1056/NEJMoa066838. N Engl J Med. 2007. PMID: 17538086 Clinical Trial.